Editorial: Let's stop the Donnybrook. A perspective on the UGDP-Biometric Society Study.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000574:American Medical Association; D001699:Biometry; D002318:Cardiovascular Diseases / Q000401:mortality*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009316:National Institutes of Health (U.S.); D010506:Periodicals as Topic; D010629:Phenformin / Q000008:administration & dosage / Q000009:adverse effects; D011643:Publishing; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D010629:Phenformin